Roof Eidam & Maycock ADV lessened its holdings in Cigna Corp (NYSE:CI) by 4.6% during the third quarter, Holdings Channel.com reports. The firm owned 4,105 shares of the health services provider’s stock after selling 200 shares during the quarter. Roof Eidam & Maycock ADV’s holdings in Cigna were worth $623,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also made changes to their positions in CI. Redhawk Wealth Advisors Inc. bought a new position in Cigna during the second quarter valued at approximately $28,000. Virtus ETF Advisers LLC bought a new position in Cigna during the second quarter valued at approximately $30,000. Garrett Wealth Advisory Group LLC bought a new position in Cigna during the third quarter valued at approximately $30,000. Knuff & Co LLC bought a new position in Cigna during the third quarter valued at approximately $30,000. Finally, Optimum Investment Advisors increased its holdings in Cigna by 258.6% during the third quarter. Optimum Investment Advisors now owns 208 shares of the health services provider’s stock valued at $32,000 after buying an additional 150 shares during the last quarter. Institutional investors and hedge funds own 87.40% of the company’s stock.
In related news, CEO David Cordani acquired 32,509 shares of the firm’s stock in a transaction that occurred on Monday, September 9th. The stock was bought at an average price of $155.17 per share, for a total transaction of $5,044,421.53. 0.80% of the stock is owned by company insiders.
A number of analysts have commented on the stock. Deutsche Bank set a $210.00 target price on shares of Cigna and gave the company a “buy” rating in a report on Friday, November 1st. Mizuho upped their target price on shares of Cigna from $180.00 to $205.00 and gave the company a “buy” rating in a report on Wednesday, November 6th. Stephens set a $225.00 price objective on shares of Cigna and gave the stock a “buy” rating in a research note on Friday, August 23rd. Morgan Stanley increased their price objective on shares of Cigna from $207.00 to $208.00 and gave the stock an “overweight” rating in a research note on Thursday, September 26th. Finally, Citigroup reissued a “buy” rating and issued a $221.00 price objective (up from $203.00) on shares of Cigna in a research note on Tuesday, November 5th. Three research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $213.84.
CI traded down $1.16 during trading on Monday, hitting $187.04. 846,469 shares of the company traded hands, compared to its average volume of 2,439,123. The company has a market cap of $67.91 billion, a PE ratio of 13.15, a P/E/G ratio of 0.92 and a beta of 0.72. The stock’s 50-day simple moving average is $163.40 and its two-hundred day simple moving average is $160.81. Cigna Corp has a 1 year low of $141.95 and a 1 year high of $226.60. The company has a current ratio of 0.63, a quick ratio of 0.63 and a debt-to-equity ratio of 0.76.
Cigna (NYSE:CI) last posted its earnings results on Thursday, October 31st. The health services provider reported $4.54 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $4.37 by $0.17. The company had revenue of $35.83 billion during the quarter, compared to analysts’ expectations of $34.20 billion. Cigna had a net margin of 3.30% and a return on equity of 12.79%. Cigna’s quarterly revenue was up 213.1% on a year-over-year basis. During the same period last year, the company posted $3.84 earnings per share. Equities analysts expect that Cigna Corp will post 16.93 EPS for the current year.
Cigna Company Profile
Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.
Recommended Story: What is the Dividend Aristocrat Index?
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corp (NYSE:CI).
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.